The University of Florida College of Medicine is the medical school of the University of Florida. It is part of the J. Hillis Miller Health Science Center, with facilities in Gainesville and Jacksonville, Florida.

During the past decade, University of Florida College of Medicine conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 36 clinical trials were completed, i.e. on average, 67.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 15 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida College of Medicine" #1 sponsor was "Medical College of Wisconsin" with 8 trials, followed by "Baxalta now part of Shire" with 6 trials sponsored, "Grifols Therapeutics LLC" with 4 trials sponsored, "Brainsway" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida College of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "National Marrow Donor Program" with 8 trials as a collaborator and "Baxalta Innovations GmbH, now part of Shire" with 3 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida College of Medicine" are "Hemophilia A" (6 trials), "Alpha 1-Antitrypsin Deficiency" (3 trials), "Cystic Fibrosis" (3 trials), "Pompe Disease" (3 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "University of Florida College of Medicine" in a lesser frequency.

Most popular intervention types in "University of Florida College of Medicine" are "Drug" (55 trials), "Biological" (16 trials), "Device" (10 trials), "Other" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Cyclophosphamide" (4 trials), "PEGylated Recombinant Factor VIII" (3 trials), "Sham Treatment" (3 trials) and "Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida College of Medicine" are 86 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Florida College of Medicine". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 60 completed trials in University of Florida College of Medicine, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida College of Medicine, 16 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".